SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-524742"
 

Sökning: id:"swepub:oai:DiVA.org:uu-524742" > Polycystic ovary sy...

Polycystic ovary syndrome and risk of pre‐eclampsia : A national register‐based cohort study

Valdimarsdottir, Ragnheidur (författare)
Uppsala universitet,Reproduktiv hälsa
Vanky, Eszter (författare)
Department of Clinical and Molecular Medicine Norwegian University of Science and Technology Trondheim Norway;Department of Obstetrics and Gynaecology St. Olavs Hospital, Trondheim University Hospital Trondheim Norway
Elenis, Evangelia, 1983- (författare)
Uppsala universitet,Reproduktiv hälsa
visa fler...
Lindström, Linda, 1978- (författare)
Uppsala universitet,Klinisk obstetrik
Junus, Katja, 1982- (författare)
Uppsala universitet,Klinisk obstetrik
Jonsson, Maria, 1966- (författare)
Uppsala universitet,Klinisk obstetrik
Sundström Poromaa, Inger, 1964- (författare)
Uppsala universitet,Reproduktiv hälsa
Wikström, Anna-Karin, 1965- (författare)
Uppsala universitet,Klinisk obstetrik
visa färre...
 (creator_code:org_t)
John Wiley & Sons, 2023
2023
Engelska.
Ingår i: British Journal of Obstetrics and Gynecology. - : John Wiley & Sons. - 1470-0328 .- 1471-0528.
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Objective: To explore whether the association between polycystic ovary syndrome (PCOS) and pre-eclampsia depends on treated clinical hyperandrogenism and whether PCOS is associated with different subtypes of pre-eclampsia.Design: Nationwide register-based cohort study.Setting: Sweden.Population: Nulliparous women with PCOS (n = 22 947) and non-PCOS controls (n = 115 272) giving singleton birth at ≥22 gestational weeks during 1997-2015. Treated clinical hyperandrogenism was defined as filled prescriptions of anti-androgenic drugs during 2005-2017 (n = 2301 among PCOS women).Methods: The risk of pre-eclampsia was estimated with conditional logistic regression, expressed as adjusted odds ratio (OR) with 95% confidence interval (CI). Adjustments were performed individually for confounders and predictors.Main outcome measures: Overall pre-eclampsia. Early/late (delivery <34/≥34 weeks) pre-eclampsia. Pre-eclampsia with or without a small-for-gestational-age (SGA) infant.Results: Compared with controls, women with PCOS had a 29% increased risk of pre-eclampsia (predictor adjusted OR 1.29, 95% CI 1.20-1.39), with similar risk estimates for PCOS women with and without treated clinical hyperandrogenism. The association between PCOS and early pre-eclampsia seemed stronger than its association with late pre-eclampsia (predictor adjusted OR 1.64 (95% CI 1.33-2.02) and 1.26 (95% CI 1.17-1.37). Additionally, the association seemed slightly stronger between PCOS and pre-eclampsia in women with an SGA infant than without.Conclusions: Women with PCOS face an increased risk for pre-eclampsia, especially early pre-eclampsia and pre-eclampsia with an SGA infant. We were unable to determine on the basis of available data, whether hyperandrogenism is associated with pre-eclampsia.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)

Nyckelord

hyperandrogenism
polycystic ovary syndrome
pre-eclampsia
pregnancy complications
preterm birth
small for gestational age.
Obstetrik och gynekologi
Obstetrics and Gynaecology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy